Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

ClinicalTrials.gov ID: NCT00003196

Public ClinicalTrials.gov record NCT00003196. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 12:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Induction of Mixed Hematopoietic Chimerism in Older Patients With B-Cell Malignancies and in Selected Other Diseases, Using Low Dose TBI , PBSC Infusion and Post-Transplant Immunosuppression With Cyclosporine and Mycophenolate Mofetil to be Followed by Donor Lymphocyte Infusion: A Pilot Study.

Study identification

NCT ID: NCT00003196
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Fred Hutchinson Cancer Center; Other
Enrollment: 63 participants

Conditions and interventions

Conditions

Interventions

allogeneic hematopoietic stem cell transplantation Procedure
chemotherapy Drug
cyclosporine Drug
mycophenolate mofetil Drug
peripheral blood stem cell transplantation Procedure
therapeutic allogeneic lymphocytes Biological
total-body irradiation Radiation

Procedure · Drug · Biological + 1 more

Eligibility (public fields only)

Age range: 50 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 1997
Primary completion: Mar 31, 2002
Completion: Mar 31, 2002
Last update posted: Dec 26, 2019

1997 – 2002

United States locations

U.S. sites: 3
U.S. states: 2
U.S. cities: 3

Facility	City	State	ZIP	Site status
City of Hope Medical Center	Duarte	California	91010	—
Stanford University Hospitals and Clinics	Stanford	California	94305	—
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium	Seattle	Washington	98109	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00003196, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 26, 2019 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003196 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →